SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia-Reference-Cited by-同舟云学术

SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia

Published:2020-10 Issue: Volume:130 Page:110629
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chen Wei,Zhang Jie,Qin Xijian,Wang Weixiao,Xu Miaomiao,Wang Lin-Fa,Xu Chuanjun,Tang Shuangshuang,Liu Pei,Zhang Libo,Liu Xuan,Zhang Yongchen,Yi Changhua,Hu Zhiliang,Yi Yongxiang

Funder

iangsu province medical youth talent

anjing medical science and technique development foundation

ACS IRG (

National Medical Research Council

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference26 articles.

1. COVID-19: towards controlling of a pandemic;Bedford;Lancet,2020

2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020

3. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in Nanjing, China, science China;Hu;Life Sci.,2020

4. A novel coronavirus from patients with pneumonia in China, 2019;Zhu;New Engl. J. Med.,2020

5. Presumed asymptomatic carrier transmission of COVID-19;Bai;JAMA,2020

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccination effect on patients with Delta variant of COVID-19 pneumonia: a study of longitudinal dynamic chest CTs using artificial intelligence model;Chinese Journal of Academic Radiology;2024-02-18

2. Negative association between ascaris lumbricoides seropositivity and Covid-19 severity: insights from a study in Benin;Frontiers in Immunology;2023-08-09

3. Neutralizing Antibodies against SARS-CoV2;Medical Journal of Dr. D.Y. Patil Vidyapeeth;2023-06-02

4. Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan;Journal of Microbiology, Immunology and Infection;2023-06

5. SARS-CoV-2 intra-host diversity, antibody response, and disease severity after reinfection by the variant of concern Gamma in Brazil;Scientific Reports;2023-05-05